Skip to content

The early predictive value of serum and urine nephrase in hypertensive nephropathy and diabetic nephropathy

The early predictive value of serum and urine nephrase in hypertensive nephropathy and diabetic nephropathy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053553
Enrollment
Unknown
Registered
2021-11-24
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Nephropathy and Hypertensive Kidney Damage

Interventions

normal albuminuria group, microalbuminuria group and macroalbuminuria group :Nil

Sponsors

Ya'an People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged > 18 years; 2. Meet the diagnostic criteria in the ''2018 China Guidelines for the Prevention and Treatment of Hypertension'', diagnosed as essential hypertension; meet the diagnostic criteria for the 2017 China Guidelines for the Prevention and Treatment of Type 2 Diabetes; 3. eGFR >= 60ml/min; 4. Various antihypertensive drugs such as oral diuretics, ACEI/ARB, calcium ion antagonists, beta blockers, etc. are required to control blood pressure; 5. Cardiac function NYHA class I-II; 6. Complete clinical data and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Primary kidney disease, other secondary kidney disease; 2. Abnormal liver function, severe cardiovascular and cerebrovascular diseases, thyroid diseases; 3. Acute and chronic urinary tract infections and other infectious diseases, severe wasting diseases, and genetic diseases; 4. Autoimmune diseases, blood system diseases, malignant tumors; 5. Have recently taken glucocorticoids, immunosuppressants, and nephrotoxic drugs; 6. Pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
renalase;

Countries

China

Contacts

Public ContactXue Hen

Ya'an People's Hospital

445960797@qq.com+86 13551595279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026